RE: NICE Approval9 Aug 2022 13:24
Although you make some reasonable points, Guy ... there’s a “but” on 2 points
1.....I’m not denying where we are and in part of why, but......it’s not that many of “like to pretend we are satisfied with everything, etc etc of your comment.” of course we’re not.
But....It’s that we have accepted and realise what’s happened...the past.... and now to move on of what we have to offer now and in the future.......And that (this old chestnut) constant negativity doesn’t help anyone or the sp, therefore not helping yourselves.
The future sooner or later is coming and it will be (and this is the key bit) much better than the past.
2.... the other but is about your Tesco response....
Has nothing to do with what I was saying.
Your response was as if I asked..... black or white? And your answer was “round”..... not even “grey”
My point was simple..... saving money, being frugal. Whilst at the same time, spending money on the important factors such as children’s future and how it will impact on them.
If these children (new borns) need the necessary attention and that golden hour can make an insurmountable difference then it’s a total no brainer. If, as a bonus, a supportive argument in evaluating if worthwhile or not is “cost saving,” then they work hand in hand.
Let’s not forget too, as mentioned several times now either by myself or others, that the NHS have staked their name on this. Pretty much claiming it’s their (pardon the pun) baby. So I feel very strongly that this is coming... the way forward across the NHS, as well as USA and Europe and potentially global.
Then we’ll see big bucks, annually.
For me and I think for some others it’s not just about AIHL but about the base line science of genomics.
AIHL is targeted specifically to the loss of hearing angle but the core technology can span right across the medical spectrum in detection. This is the main reason I think that is why we could very easily be a buyout/takeover target for larger pharmas.
UNB1